Literature DB >> 15937104

Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior.

Lina Yao1, Krista McFarland, Peidong Fan, Zhan Jiang, Yuichiro Inoue, Ivan Diamond.   

Abstract

The nucleus accumbens (NAc) is central to heroin addiction. Activation of opiate receptors in the NAc dissociates G(i/o) into alpha and betagamma subunits. Galpha(i) inhibits cAMP production, but betagamma regulates several molecular pathways, including protein kinase A (PKA). We show in NAc/striatal neurons that opiates paradoxically activate PKA signaling by means of betagamma dimers. Activation requires Galpha(i3) and an activator of G protein signaling 3 (AGS3). AGS3 competes with betagamma for binding to Galpha(i3)-GDP and enhances the action of unbound betagamma. AGS3 and Galpha(i3) knockdown prevents opiate activation of PKA signaling. In rats self-administering heroin, AGS3 antisense in the NAc core, but not shell, eliminates reinstatement of heroin-seeking behavior, a model of human relapse. Thus, Galpha(i3)/betagamma/AGS3 appears to mediate mu opiate receptor activation of PKA signaling as well as heroin-seeking behavior.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937104      PMCID: PMC1142483          DOI: 10.1073/pnas.0503419102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin.

Authors:  A L Svingos; A Moriwaki; J B Wang; G R Uhl; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

2.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Authors:  H W Matthes; R Maldonado; F Simonin; O Valverde; S Slowe; I Kitchen; K Befort; A Dierich; M Le Meur; P Dollé; E Tzavara; J Hanoune; B P Roques; B L Kieffer
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

Review 3.  Molecular and cellular basis of addiction.

Authors:  E J Nestler; G K Aghajanian
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

4.  Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin.

Authors:  A L Svingos; C L Clarke; V M Pickel
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

5.  The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins.

Authors:  S E Senogles
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

6.  Differential modulation of adenylyl cyclases I and II by various G beta subunits.

Authors:  M L Bayewitch; T Avidor-Reiss; R Levy; T Pfeuffer; I Nevo; W F Simonds; Z Vogel
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

7.  Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.

Authors:  J S Chan; T T Chiu; Y H Wong
Journal:  J Neurochem       Date:  1995-12       Impact factor: 5.372

8.  Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking.

Authors:  M Scott Bowers; Krista McFarland; Russell W Lake; Yuri K Peterson; Christopher C Lapish; Mary Lee Gregory; Stephen M Lanier; Peter W Kalivas
Journal:  Neuron       Date:  2004-04-22       Impact factor: 17.173

9.  G protein heterotrimer Galpha13beta1gamma3 couples the angiotensin AT1A receptor to increases in cytoplasmic Ca2+ in rat portal vein myocytes.

Authors:  N Macrez-Leprêtre; F Kalkbrenner; J L Morel; G Schultz; J Mironneau
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

10.  Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.

Authors:  T Avidor-Reiss; M Bayewitch; R Levy; N Matus-Leibovitch; I Nevo; Z Vogel
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

View more
  46 in total

1.  Receptor-regulated interaction of activator of G-protein signaling-4 and Galphai.

Authors:  Sukru Sadik Oner; Ellen M Maher; Billy Breton; Michel Bouvier; Joe B Blumer
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 2.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

3.  Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats.

Authors:  Lina Yao; Krista McFarland; Peidong Fan; Zhan Jiang; Takashi Ueda; Ivan Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

Review 4.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

5.  Intersection of two key signal integrators in the cell: activator of G-protein signaling 3 and dishevelled-2.

Authors:  Ali Vural; Stephen M Lanier
Journal:  J Cell Sci       Date:  2020-09-04       Impact factor: 5.285

6.  A specific role of AGS3 in the surface expression of plasma membrane proteins.

Authors:  B Groves; Q Gong; Z Xu; C Huntsman; C Nguyen; D Li; D Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

Review 7.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

8.  Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.

Authors:  Joe B Blumer; Kevin Lord; Thomas L Saunders; Alejandra Pacchioni; Cory Black; Eric Lazartigues; Kurt J Varner; Thomas W Gettys; Stephen M Lanier
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  The PDZ and band 4.1 containing protein Frmpd1 regulates the subcellular location of activator of G-protein signaling 3 and its interaction with G-proteins.

Authors:  Ningfei An; Joe B Blumer; Michael L Bernard; Stephen M Lanier
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

Review 10.  Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal.

Authors:  Nobue Kitanaka; Junichi Kitanaka; F Scott Hall; Tomohiro Tatsuta; Yoshio Morita; Motohiko Takemura; Xiao-Bing Wang; George R Uhl
Journal:  Synapse       Date:  2008-09       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.